Literature DB >> 16643577

Migraine prevention: what patients want from medication and their physicians (a headache specialty clinic perspective).

Todd D Rozen1.   

Abstract

OBJECTIVE: To document the results of a migraine patients survey, from a headache specialty clinic, in which patients were asked to rank, in order of importance, certain characteristics of migraine preventive treatment.
METHODS: A 10-question survey was completed by 150 patients (114 females and 36 males) with a history of migraine who presented to the Michigan Head Pain & Neurological Institute. The patients were asked to rank, in order of importance, characteristics of migraine preventive treatment. Each characteristic was rated individually on a 1 to 10 scale (1 being of little importance and 10 being extremely important). The mean rating of each characteristic was then calculated and the results analyzed. RESULTS/DISCUSSION: From this migraine preventive treatment survey, the most important thing to migraineurs, from a headache specialty clinic population, is that the prescribing physician involves them in the decision making of choosing a preventive agent. The physician taking time to explain the possible medication side effects is the second most highly ranked characteristic. Migraine preventives with published efficacy in the medical literature are also deemed very important. Migraineurs do not mind using more than 1 preventive agent at one time if greater efficacy can be achieved. Agents that may affect weight and/or cause sedation may be important factors as to why patients (especially females) may not want to take a preventive medication. Natural therapies and once-daily dosing are ranked lower overall but still are important characteristics of preventive treatment. Some gender differences are noted in the ranking of migraine preventive characteristics.

Entities:  

Mesh:

Year:  2006        PMID: 16643577     DOI: 10.1111/j.1526-4610.2006.00429.x

Source DB:  PubMed          Journal:  Headache        ISSN: 0017-8748            Impact factor:   5.887


  12 in total

Review 1.  A descriptive review on methods to prioritize outcomes in a health care context.

Authors:  Inger M Janssen; Ansgar Gerhardus; Milly A Schröer-Günther; Fülöp Scheibler
Journal:  Health Expect       Date:  2014-08-25       Impact factor: 3.377

2.  Prophylactic treatment of migraine by GPs: a qualitative study.

Authors:  Frans Dekker; Arie Knuistingh Neven; Boukje Andriesse; David Kernick; Michel D Ferrari; Willem J J Assendelft
Journal:  Br J Gen Pract       Date:  2012-04       Impact factor: 5.386

3.  Patient-reported outcomes of migraine treatment with erenumab: results from a national patient survey.

Authors:  Austėja Dapkutė; Jurgita Vainauskienė; Kristina Ryliškienė
Journal:  Neurol Sci       Date:  2022-01-10       Impact factor: 3.830

4.  Practical strategies for treating chronic migraine with medication overuse: case examples and role play demonstrations.

Authors:  Randall E Weeks
Journal:  Neurol Sci       Date:  2009-05       Impact factor: 3.307

Review 5.  Key points in migraine prophylaxis: patient perspective.

Authors:  Domenico D'Amico; S J Tepper
Journal:  Neurol Sci       Date:  2009-05       Impact factor: 3.307

6.  Prophylactic treatment of migraine; the patient's view, a qualitative study.

Authors:  Frans Dekker; Arie Knuistingh Neven; Boukje Andriesse; David Kernick; Ria Reis; Michel D Ferrari; Willem J J Assendelft
Journal:  BMC Fam Pract       Date:  2012-03-09       Impact factor: 2.497

7.  Transcutaneous supraorbital neurostimulation in "de novo" patients with migraine without aura: the first Italian experience.

Authors:  Antonio Russo; Alessandro Tessitore; Francesca Conte; Laura Marcuccio; Alfonso Giordano; Gioacchino Tedeschi
Journal:  J Headache Pain       Date:  2015-07-22       Impact factor: 7.277

Review 8.  Efficacy and Safety of Galcanezumab for the Preventive Treatment of Migraine: A Narrative Review.

Authors:  Vincent Martin; Karen Hamrick Samaan; Sheena Aurora; Eric M Pearlman; Chunmei Zhou; Xiaoping Li; Robert Pallay
Journal:  Adv Ther       Date:  2020-04-21       Impact factor: 3.845

9.  Prophylaxis of migraine: general principles and patient acceptance.

Authors:  Domenico D'Amico; Stewart J Tepper
Journal:  Neuropsychiatr Dis Treat       Date:  2008-12       Impact factor: 2.570

10.  Hair Transplantation in Migraine Headache Patients.

Authors:  Safvet Ors
Journal:  Plast Reconstr Surg Glob Open       Date:  2017-09-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.